Company page

Innate Pharma Sa Class A

Innate Pharma Sa Class A, traded under the ticker IPH, is a public company based in France with a market capitalization of approximately €171.93 million. The company focuses on developing innovative immunotherapy treatments for cancer. Its research and development efforts aim to enhance the effectiveness of cancer therapies and improve patient outcomes.